Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. (CBYL) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 58 transactions totaling $33.1M, demonstrating a bullish sentiment with $33.0M in net insider flow. The most recent transaction on Nov 21, 2016 involved a transaction of 4,664 shares valued at $36.6K.
CBYL Insider Activity Summary
Who Is Buying CBYL Stock?
No significant insider buying has been recorded for CBYL in the recent period.
Who Is Selling CBYL Stock?
No significant insider selling has been recorded for CBYL in the recent period.
Is Carbylan Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CBYL is bullish with an Insider Alignment Score of 100/100 and a net flow of $33.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CBYL Frequently Asked Questions
Understanding CBYL Insider Activity
Insider trading at Carbylan Therapeutics, Inc. (CBYL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading CBYL stock, having executed 58 transactions in the past 90 days. The most active insider is Albert Cha (Executive), who has made 16 transactions totaling $10.1M.
Related Tools
Track Carbylan Therapeutics, Inc. Insider Activity
Get notified when executives and directors at CBYL file new Form 4 transactions